0001771442-19-000001.txt : 20190401 0001771442-19-000001.hdr.sgml : 20190401 20190329200514 ACCESSION NUMBER: 0001771442-19-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190401 DATE AS OF CHANGE: 20190329 EFFECTIVENESS DATE: 20190401 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Secura Bio, Inc. CENTRAL INDEX KEY: 0001771442 IRS NUMBER: 364922937 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-336108 FILM NUMBER: 19718431 BUSINESS ADDRESS: STREET 1: 11988 EL CAMINO REAL STREET 2: SUITE 650 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: 8582511414 MAIL ADDRESS: STREET 1: 11988 EL CAMINO REAL STREET 2: SUITE 650 CITY: SAN DIEGO STATE: CA ZIP: 92130 D 1 primary_doc.xml X0708 D LIVE 0001771442 Secura Bio, Inc. 11988 EL CAMINO REAL SUITE 650 SAN DIEGO CA CALIFORNIA 92130 8582511410 DELAWARE None None Corporation true 2019 Joseph Limber 11988 El Camino Real Suite 650 San Diego CA CALIFORNIA 92130 Executive Officer Director Brett Lund 11988 El Camino Real Suite 650 San Diego CA CALIFORNIA 92130 Executive Officer Director Mark Spring 11988 El Camino Real Suite 650 San Diego CA CALIFORNIA 92130 Executive Officer Director Juan Estruch 11988 El Camino Real Suite 650 San Diego CA CALIFORNIA 92130 Executive Officer Pharmaceuticals No Revenues 06b false 2019-03-01 true true false 10000000 90000000 50000000 40000000 $90M represents a debt offering of which $50M in initial notes is outstanding and $40M remains to be issued as delayed draw notes, but there is a commitment by an investor to purchase. false 2 0 0 0 true Certain portions of the proceeds to be used in Issuer's general operating account which will be used for compensation of employees, including executive officers. false Secura Bio, Inc. /s/ Mark Spring Mark Spring Chief Financial Officer 2019-03-29